Design considerations for observational studies of drugs for advanced cancer
Pharmacoepidemiol Drug Saf
.
2023 Jul;32(7):812-815.
doi: 10.1002/pds.5612.
Epub 2023 Mar 22.
Authors
Xabier Garcia-Albeniz
1
,
Pär Stattin
2
,
Marcus Westerberg
2
,
Rachel Weinrib
1
,
Per Sandstrom
3
,
Zdravko Vassilev
3
Affiliations
1
Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain.
2
Department of Surgical Sciences, Urology, Uppsala University, Uppsala, Sweden.
3
Bayer US, Whippany, New Jersey, USA.
PMID:
36920321
DOI:
10.1002/pds.5612
No abstract available
Keywords:
causal inference; real world evidence; target trial emulation.
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Comparative Effectiveness Research
Humans
Neoplasms* / drug therapy
Grants and funding
Bayer